Members

Approved

GaiverGamma GaiverGamma

Approved

angelinatp4 angelinatp4

Approved

Glenford Robinson

Fintech
Benzinga BioTech
Investment News
Stocks to Watch
Finance
Most Popular News Articles
Bitcoin News
Technology News
Stocks and Commodities
Emerging Markets
Economy
Nasdaq Stock News
Mstardom Finance
FDA Press Releases RSS Feed
What's New: Drugs RSS Feed
ECB - European Central Bank
FRB: Press Release - All Releases
Press Releases
St. Louis Fed - Recent Research
Research Announcements – St. Louis Fed Economic Research
Investor Alerts and Bulletins
SEC.gov Updates: Litigation Releases
SEC.gov Updates: Proposed Rules

Altcoin.io Acquired by BnkToTheFuture to Launch Non-Custodial Securities Token Exchange

16 June 2019 - PRNewswire

SAN FRANCISCO, June 16, 2019 /PRNewswire/ -- Altcoin.io, a decentralized ...

Full story available on Benzinga.com

The Week Ahead In Biotech: Conferences, PDUFA Dates Clinical Trial Readouts And IPOs

15 June 2019 - Shanthi Rexaline

For biotech stocks, the week was back loaded with multiple conferences scheduled for the later half of the week. Nevertheless, there were volatile moves in some low-float, thinly traded stocks.

Looking ahead, keep an eye on the following key catalysts.

Conferences The Annual European Congress of Rheumatology of the European League Against Rheumatism - June 12-16, in Switzerland 24th European Hematology Association Congress – June 13-16, in Amsterdam, Netherlands European Society of Human Genetics Conference – June 15-18, in Gothenburg, Sweden The International Association of Parkinson's Disease and Related Disorders (IAPR) World Congress on Parkinson's Disease and Related Disorders – June 16-19, Montreal, Canada 5th International Conference on Influenza and Zoonotic Diseases - June 17-18, in Berlin, Germany 9th World Congress on Rare Diseases and Orphan Drugs - June 17-18, in Berlin International Conference On Malignant Lymphoma – June 18-20, in Switzerland Oxalosis Hyperoxaluria Foundation, or OHF, International Hyperoxaluria Workshop – June 21-22, in Boston, Massachusetts

Related Link: Attention Biotech Investors: Mark Your Calendar For These June PDUFA Dates

PDUFA Dates

The FDA is set to rule on Merck & Co., Inc. (NYSE: MRK)'s sBLA in Keytruda for treating patients with advanced small cell lung cancer, whose disease has progressed after two or more lines of prior therapy. The PDUFA date is scheduled for Monday, June 17.

Clinical ...

Full story available on Benzinga.com

Stocks to Watch: DuPont, Nike, KB Home are stocks to watch

27 June 2014

Among the companies whose shares are expected to see active trade in Friday’s session are DuPont, Nike, and KB Home.

Progressive's Dashboard Report: May 2019 Update

16 June 2019

United Technologies And Raytheon Merger - Strong Investment Opportunity

10 June 2019

VPN Providers Defy Order to Connect to Russia’s Internet Censor

16 June 2019 - Lubomir Tassev

VPN Providers Defy Order to Connect to Russia’s Internet Sensor Russian regulators have once again moved to expand oversight of the online space in an attempt to ensure compliance with various restrictions Moscow is trying to impose. But as in other cases, their efforts have been met with resistance. Over a dozen VPN platforms, popular among crypto enthusiasts and other privacy-conscious users, have refused to […]

The post VPN Providers Defy Order to Connect to Russia’s Internet Censor appeared first on Bitcoin News.

No items.

EUR-USD Bullish on US-China Raging Trade War

13 May 2019 - Glenford Robinson

The Mstardom Finance trading group is predicting that the next short-term target for the EUR/USD currency pair is 1.1305. The pair has met support at the 1.1253 area and resistance at the 1.1263 area. This price action is inline with our calculated and predicted price movements. If our bullish prediction doesn't hold, then a pullback to the 1.1216 area is expected.

Statement from FDA Commissioner Scott Gottlieb, M.D. and Jeff Shuren, M.D., Director of the Center for Devices and Radiological Health, on latest steps to strengthen FDA’s 510(k) program for premarket review of medical devices

16 June 2019 - FDA

FDA takes more steps toward strengthening 510(k) program for premarket review of medical devices

Rare Diseases: Early Drug Development and the Role of Pre-IND Meetings

16 June 2019 - FDA

The purpose of this guidance is to assist sponsors of drug and biological products for the 19 treatment of rare diseases in early development and in the planning of and participation in formal 20 pre-investigational new drug application (pre-IND) meetings with the Food and Drug 21 Administration (FD

Luis de Guindos: Interview with Corriere della Sera

15 June 2019

Federal Reserve Board requests public comment on technical updates to its Freedom of Information Act procedures and on changes to its rules governing the disclosure of confidential supervisory information

14 June 2019

Industrial and Commercial Bank of China Affiliate to Pay More Than $42 Million for Improper Handling of ADRs

14 June 2019

The Securities and Exchange Commission today announced that Industrial and Commercial Bank of China Financial Services LLC (ICBCFS), a wholly-owned subsidiary of Industrial and Commercial Bank of China Limited, will pay more than $42 million to settle charges for improper handling of “pre-released” American Depositary Receipts (ADRs). The settlement marks the largest recovery against a broker in the SEC’s ongoing investigation of ADR practices, which thus far has resulted in settlements with 10 financial institutions exceeding $414 million.

ADRs – U.S. securities that represent foreign shares of a foreign company – require a corresponding number of foreign shares to be held in custody at a depositary bank. The practice of “pre-release” allows ADRs to be issued without the deposit of foreign shares, provided brokers receiving them have an agreement with a depositary bank and the broker or its customer owns the number of foreign shares that corresponds to the number of shares the ADRs represent.

The SEC’s order finds that ICBCFS improperly obtained pre-released ADRs from depositary banks when ICBCFS should have known that neither the firm nor its customers owned the foreign shares needed to support those ADRs. This inflated the total number of a foreign issuer’s tradeable securities and resulted in abusive practices such as inappropriate short selling and dividend arbitrage. In certain countries, demand for ADR borrowing increased around dividend record dates, so that certain tax-advantaged borrowers could – through a series of transactions – collect dividends without any corresponding tax withholding. Pre-released ADRs that were improperly obtained by ICBCFS were used to satisfy that demand.

“With these charges, ICBCFS is being held accountable for its unlawful ADR practices,” said Sanjay Wadhwa, Senior Associate Director of the SEC’s New York Regional Office. “By falsely representing that the firm or its customers owned the foreign shares to support pre-release transactions, ICBCFS often played the role of middleman between depositary banks and other market participants in the issuance of what amounted to phantom securities.”

The SEC’s order finds that ICBCFS violated the antifraud provisions of Section 17(a)(3) of the Securities Act of 1933 and failed reasonably to supervise its securities lending desk personnel. Without admitting or denying the SEC’s findings, ICBCFS agreed to be censured, return nearly $24 million in ill-gotten gains, and pay $4.4 million in prejudgment interest and a $14.3 million penalty.

The U.S. Department of Justice’s Antitrust Division today separately announced that ICBCFS pled guilty to an antitrust charge relating to the bid-rigging of pre-released ADRs by the same securities lending desk.

The SEC’s continuing investigation is being conducted by Andrew Dean, Elzbieta Wraga, Philip Fortino, Joseph P. Ceglio, Richard Hong, and Adam Grace of the New York Regional Office, and is being supervised by Mr. Wadhwa.

Why Is the St. Louis Metro Area Population Growing So Slowly?

31 May 2019

By Charles S. Gascon in Economic Synopses. According to an economic model, St. Louis should have grown 11% since 2000 but grew 4.7%.

St. Louis: Growing Slowly

3 June 2019

Expected growth: 11%. Actual growth: 4.7%. Read why.

Updated Investor Bulletin: Regulation A

24 May 2019

The SEC’s Office of Investor Education and Advocacy is issuing this Investor Bulletin to educate investors about Regulation A. Regulation A is an exemption from registration under the Securities Act that allows companies to raise money from the public in securities offerings of up to $50 million.

Alton Perkins, et al.

14 June 2019

SEC Charges North Carolina Businessman and His Companies with Fraudulent Offering Scam

Securities Offering Reform for Closed-End Investment Companies

20 March 2019

EUR-USD Bullish on US-China Raging Trade War

The Mstardom Finance trading group is predicting that the next short-term target for the EUR/USD currency pair is 1.1305. The pair has met support at the 1.1253 area and resistance at the 1.1263 area. This price action is inline with our calculated and predicted price movements. If our bullish prediction doesn’t hold, then a pullback to the 1.1216 area is expected.

Global Clinical Alarm Management Market to 2023 with Koninklijke Philips, Vocera, Ascom, Spok, Bernoulli, Connexall, Mobile Heartbeat, GE Healthcare, Capsule Technologie & Masimo Dominating

In 2018, North America is expected to account for the largest share of the global clinical alarm management market. The large share of this region can be attributed to the increasing cases of alarm fatigue and initiatives by government bodies to curtail the effects of alarm fatigue and the increasing need for integrated healthcare IT systems to ensure reliability, efficient maintenance of data, data integrity, and timely availability of patient data to authorized healthcare professionals.

66 Nobel Laureates Urge India and Pakistan to Defuse Tension

This is the first time ever such a large number of Nobel Laureates ranging from peace laureates to those from the fields of economics, chemistry, physics and medicine have come together with a joint appeal to call attention to the lives and future of more than half a billion children in India and Pakistan that are at stake.

SS&C GlobeOp Hedge Fund Performance Index and Capital Movement; IndexSS&C GlobeOp Hedge Fund Performance Index: February performance 1.24%; Capital Movement Index: March net flows advance 0.21%

The SS&C GlobeOp Hedge Fund Performance Index is an asset-weighted, independent monthly window on hedge fund performance. On the ninth business day of each month it provides a flash estimate of the gross aggregate performance of funds for which SS&C GlobeOp provides monthly administration services on the SS&C GlobeOp platform. Interim and final values, both gross and net, are provided in each of the two following months, respectively. Online data can be segmented by gross and net performance, and by time periods. The SS&C GlobeOp Hedge Fund Performance Index is transparent, consistent in data processing, and free from selection or survivorship bias. Its inception date is January 1, 2006.

The Conference Board Leading Economic Index® (LEI) for the U.S. Increased; Economy to Continue Expanding in Near-Term

The ten components of The Conference Board Leading Economic Index® for the U.S. include:Average weekly hours, manufacturingAverage weekly initial claims for unemployment insuranceManufacturers’ new orders, consumer goods and materialsISM® Index of New OrdersManufacturers’ new orders, nondefense capital goods excluding aircraft ordersBuilding permits, new private housing unitsStock prices, 500 common stocksLeading Credit Index™Interest rate spread, 10-year Treasury bonds less federal fundsAverage consumer expectations for business conditionsFor full press release and technical notes:http://www.conference-board.org/data/bcicountry.cfm?cid=1

Mstardom Finance Empowering the Investing and Trading Community!

Members

Like this:

Members

Share:

Like this: